Goldman Sachs Group Inc Taro Pharmaceutical Industries LTD Transaction History

Goldman Sachs Group Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$32.77 - $42.31 $395,599 - $510,766	-12,072 Reduced 68.15%	5,642 $235,000
Q3 2023 May 14, 2024	BUY	$35.46 - $40.13 $428,073 - $484,449	12,072 Added 213.97%	17,714 $667,000
Q3 2023 Nov 14, 2023	BUY	$35.46 - $40.13 $285,240 - $322,805	8,044 Added 83.19%	17,714 $667,000
Q2 2023 May 14, 2024	BUY	$24.24 - $40.97 $44,019 - $74,401	1,816 Added 23.12%	9,670 $366,000
Q2 2023 Aug 14, 2023	BUY	$24.24 - $40.97 $234,400 - $396,179	9,670 New	9,670 $366,000
Q3 2022 May 14, 2024	SELL	$28.74 - $39.9 $280,013 - $388,745	-9,743 Reduced 55.37%	7,854 $235,000
Q3 2022 Nov 10, 2022	SELL	$28.74 - $39.9 $280,013 - $388,745	-9,743 Reduced 55.37%	7,854 $0
Q2 2022 May 14, 2024	BUY	$35.0 - $43.59 $418,425 - $521,118	11,955 Added 211.89%	17,597 $636,000
Q2 2022 Aug 15, 2022	BUY	$35.0 - $43.59 $302,225 - $376,399	8,635 Added 96.35%	17,597 $636,000
Q1 2022 May 16, 2022	BUY	$43.12 - $50.3 $33,978 - $39,636	788 Added 9.64%	8,962 $388,000
Q4 2021 Feb 14, 2022	SELL	$47.6 - $65.0 $33,415 - $45,630	-702 Reduced 7.91%	8,174 $410,000
Q3 2021 Nov 10, 2021	BUY	$62.34 - $73.38 $553,329 - $651,320	8,876 New	8,876 $565,000

17K

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.